Schedule 13G ownership disclosure
JOUNCE THERAPEUTICS INC
Security class unavailable · CUSIP: 481116101
Event date: 2021-01-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,768,840
- Percent of class
- 6.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-21-000683
- Form type
- SC 13G
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Jan 29, 2021
- Reporting period
- Jan 19, 2021
- Description
- Schedule 13G beneficial ownership